Nifty 50

Market participants attribute largecaps outperformance over midcaps and smallcaps to signs of foreign institutional investors (FIIs) turning buyers in the secondary market after months of sustained selling.

Nifty target 26,300: CLSA’s Laurence Balanco eyes new record high; weak dollar, autos, metals driving rally

Nifty’s repeated defence of the 24,000-24,300 zone has reinforced the market’s bullish base, said Laurence Balanco. This prospective target surpasses the benchmark’s current all-time high of 26,277.35, recorded in September 2024.

Indices weighed down by ‘tired business models’, says SBI MF’s Balachandran

India’s largest asset manager warns IT, pharma and consumer heavyweights are “mature, tired models,” driving investor hunger for new-age IPOs, but valuations remain key.

Indian shares to post mild gains in fourth quarter, shows survey

The informal survey, conducted last week, signals a shift in investor view on India. A separate survey showed a recent momentum in Chinese stocks may cool, with the CSI 300 Index likely to post a modest 1.2% rise by the year end.

Max Healthcare likely to see buying from active funds on Nifty inclusion, is it a good bet? 

According to Elara Capital, active funds are underweight on Max Healthcare player by roughly Rs 11,743 crore; the Nifty inclusion will likely spur buying.

Max Healthcare, InterGlobe Aviation set to enter Nifty 50, inflows of $1 billion expected: Nuvama

IndiGo and Max Healthcare will enter the Nifty 50, while IndusInd Bank and Hero MotoCorp will make way in the upcoming Nifty 50 reshuffle.

Nifty likely to hit 27,000 in the next 12 months: Goldman Sachs analyst Sunil Koul

'India's valuation premium has definitely come down now. The catalyst for India to outperform China has to come not only from easing valuations but better growth and earnings,' said Goldman Sachs Emerging Market Equity Strategist Sunil Koul

From status quo to 50 bps rate cut: Three scenarios for Indian stock markets that will depend on Fed decision

Some analysts opine that a 25 bps rate cut by the US Federal Reserve should be expected, while others hint at a bumper 50 bps cut.

Gold or stocks? Which is the better Diwali bet?

Gold has outpaced Nifty in Diwali-to-Diwali returns since 2010, turning Rs 10,000 yearly into Rs 4.47 lakh versus Nifty 50's Rs 3.72 lakh.

Nifty, Sensex lag Asia on Rupee fall and valuation woes as investors look past GST cheer

Persistent foreign portfolio outflows, potential impact of US tariffs and stretched valuations are being cited as some of the reasons behind Indian stock markets' underperformance.

Sensex gains 555 pts, Nifty above 24,600: Upbeat Q1 GDP data among key factors behind market rise

On September 1, all sectoral indices, expect FMCG, were trading in the green with IT stocks leading the gains.

Sensex falls 1,500 points in two days, Nifty at 24,500 amid additional US tariffs; experts suggest these strategies for index traders

The weak market sentiment will likely continue as long as Nifty remains below 24,600 and Sensex below 80,600, said an analyst

Max Healthcare, InterGlobe Aviation shares slip despite Nifty 50 inclusion

Hindustan Zinc, Mazagon Dock, Siemens Energy and Solar Industries are set to join the Nifty Next 50 index during this reshuffle.

India sees Asia's biggest earnings downgrades as US tariffs loom

According to LSEG IBES data, forward 12-month earnings estimates for India's large and mid-cap firms have been cut by 1.2% in the past two weeks, the sharpest in Asia

India is now least favored Asian stock market, BofA survey shows

In the most recent fund manager survey, 30% said they are underweight on India, followed by 20% for Thailand and 10% for Malaysia

Nifty, Sensex to see muted start as tariff pressures weigh; key levels to watch on August 8

Yesterday's intraday pullback and strong close indicate possible short-term momentum building up for the sessions ahead

Max Health, Indigo may join Nifty 50; Swiggy, Dabur to exit Nifty Junior: Nuvama

Nuvama said that BSE has zero probability of being included in the Nifty 50 in the September 2025 review, no chance of joining Nifty Next 50 either.

Jane Street's two strategies to game Bank Nifty, Nifty 50

SEBI alleges that Jane Street manipulated key Indian indices using high-frequency trades to book massive profits from index options.

IndiGo, Max Healthcare may join Nifty 50 in next rejig, BSE ruled out: Nuvama

Nuvama said that BSE has zero probability of being included in the Nifty 50 in the September 2025 review, no chance of joining Nifty Next 50 either.

Nifty, perched less than 700 points from fresh highs, is poised for a bullish July, shows data

Since 2009, Nifty has had a positive close in July on 75 percent of the occasions, making it the month with the best chance of ending with gains, if only looks at the data for last 16 years.

Nifty settles off day's high, Sensex slumps 1,000 points as Israel-Iran tensions resurface; broader markets outperform

Sensex and Nifty 50 slipped over one percent each from the day's high, as tensions in the Middle East bubbled up again.

BSE, Indigo may join Nifty 50, IndusInd Bank, Hero MotoCorp to be excluded in next review: CNBC-TV18

The Nifty 50 index is reshuffled twice every year, based on six-month data ending January 31 and July 31, and the changes to the index are made in March and September.

India Vix rises up to 5 percent to reflect Middle East jitters but still lower than June highs

Despite the threat of a spiralling of conflict in the middle east this month, the India Vix has still not crossed the highs seen on June 13, the day when Israel began military action on Iran's defence and nuclear infrastructure.

Julius Baer sees consumption revival in India taking stocks to record high

The gauge is 4.6% away from its peak set in September and the central bank’s jumbo rate cut Friday is further raising expectations of a record-breaking surge.

Nifty tops 24,600, Sensex snaps 3-session losing streak; cooling volatility supports

Nifty 50 is likely to continue its ongoing consolidation phase, remaining within that key 24,000 to 25,000 range until fresh triggers emerge.